Transfusion and postpartum haemorrhage;Transfusion et hémorragie du post-partum

Transfusion Clinique et Biologique

Volumn 17, Issue 5-6, 2010, Pages 273-278

  Ducloy Bouthors, A S ^a,b   Blondé Zoonekynd, É ^a,b   Jaillette, E ^a,b   Richart, P ^a,b   Barre Drouard, C ^a,b   Wibaut, B ^a,b   Ducloy, J C ^a,b   Sicot, J ^a,b   Depret Mosser, S ^a,b   Godier, A ^c   Susen, S ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c HÔTEL DIEU   (France)

Author keywords

Anti fibrinolytic agents; Fibrinogen; Fresh frozen plasma; Postpartum haemorrhage; Recombinant activated factor VII; Thrombelastography; Tranexamic acid; Transfusion

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; FRANCE; HUMAN; MATERNAL CARE; MATERNAL MORBIDITY; MATERNAL MORTALITY; PATIENT MONITORING; POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINE; SURGICAL TECHNIQUE;

EID: 78649524921     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2010.09.156     Document Type: Article

References (31)

1. Waterstone M., Bewley S., Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001, 322:1089-1093.
2. Recommandations de pratique clinique Prise en charge de l'hémorragie du post-partum immédiat. J Gynecol Obstet Biol Reprod 2004, 33(8 Suppl.).
3. Ducloy-Bouthors A.S., Provost-Hélou N., Pougeoise M., Tournoys A., Ducloy J.C., Sicot J., et al. Prise en charge d'une hémorragie du post-partum. Reanimation 2007, 16(5):373-379.
4. Franchini M. Haemostasis and pregnancy. Thromb Haemost. 2006, 95(3):401-413.
5. Référentiel de la société française d'anesthésie réanimation et de la société Conclusion de la table ronde organisée par l'EFS sur le traitement des urgences transfusionnelles obstétricales (2000). [http://www.sfar.org/réferentiel/autres référentiels].
6. Chauleur C., Cochery-Nouvellon E., Mercier E., Aya G., Marès P., Mismetti P., et al. Analysis of the venous thromboembolic risk associated with severe post-partum haemorrhages (PPH) in the NOHA First Cohort. Thromb Haemost 2008, 100:773-779.
7. Zhang W.H., Deneux-Tharaux C., Brocklehurst P., Juszczak E., Joslin M., Alexander S. Effect of a collector bag for measurement of postpartum blood loss after vaginal delivery: cluster randomised trial in 13 European countries. BMJ 2010, 340:293.
8. Charbit D., Mandelbrot L., Samain E., Baron G., Haddaoui B., Keita H., et al. The decrease of fibrinogen is an early predictor of severity of postpartum haemorrhage. J Thromb Haemost 2007, 5:266-273.
9. Blonde-Zoednekindt É., Jaillette E. Mémoires pour le diplôme de spécialité en anesthésie-réanimation 2010, Université Lille II, Lille.
10. Ickx BE. Fluid and blood transfusion management in obstetrics. Eur J Anaesthesiol 2010;27. doi:10.1097/EJA.0b013e32833c30e3.
11. Huissoud C, Carrabin N, Audibert F, Levrat A, Massignon D, Berland M, et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 2009;116(8):1097-102.
12. Burtelow M, Riley E, Druzin M, Fontaine M, Viele M, Goodnough LT. How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion 2007;47(9):1564-72.
13. Williams J., Mozurkewich E., Chilimigras J., Van De Ven C. Critical care in obstetrics: pregnancy-specific conditions. Best Pract Res Clini Obstet Gynaecol 2008, 22(5):825-846.
14. Knight M., Callaghan W.M., Berg C., Alexander S., Bouvier-Colle M.H., Ford J.B., et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage. BMC Pregnancy Childbirth 2009, 9:55.
15. Murad MH, Stubbs JR, Gandhi MJ, Wang AT, Paul A, Erwin PJ, et al. The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion 2010;50(6):1370-83.
16. Spahn D.R., Cerny V., Coats T.J., Duranteau J., Fernández-Mondéjar E., Gordini G., et al. Task force for advanced bleeding care in trauma. Management of bleeding following major trauma: a European guideline. Crit Care 2007, 11(1):R17.
17. Wang SC, Shieh JF, Chang KY, Chu YC, Liu CS, Loong CC, et al. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc 2010;42(7):2590-3.
18. Rahe-Meyer N., Solomon C., Winterhalter M., Piepenbrock S., Tanaka K., Haverich A., et al. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. J Thorac Cardiovasc Surg 2009, 138(3):694-702.
19. Grottke O., Braunschweig T., Henzler D., Coburn M., Tolba R., Rossaint R. Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury. Crit Care 2010, 14(2):R62.
20. Bolliger D., Szlam F., Levy J.H., Molinaro R.J., Tanaka K.A. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage. Br J Anaesth 2010, 104(3):318-325.
21. Chowdhury P., Saayman A.G., Paulus U., Findlay G.P., Collins P.W. Efficacy of standard dose and 30ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004, 125(1):69-73.
22. Ducloy-Bouthors A.S., Broisin F., Teboul C., Jaffry A., Waegemans T., Padrazzi B. A multicentre prospective open-label study assessing efficacy and safety of a triple-secured fibrinogen concentrate in the treatment of postpartum haemorrhage. Crit Care 2008, 12(Suppl. 2):P224.
23. Henry D, Carless P, Moxey A, O'Connell D, Stokes BJ, McClelland B, et al. Anti-fibrinolytic use for minimising perioperative allogenic blood transfusion. Cochrane Database of Systematic Reviews 2007:CD001886.
24. CRASH-2 trial collaborators. Effects of tranexamic acid on death in vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomized placebo-controlled trial. Lancet 2010, 376:23-32.
25. Ducloy-Bouthors A., Broisin F., Keita H., Fontaine S., Depret S., Legoeff F., Jude B., et al. Tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care 2010, 14(Suppl. 1):P370.
26. Ferrer P., Roberts I., Sydenham E., Blackhall K., Shakur H. Anti-fibrinolytic agents in post partum haemorrhage: a systematic review. BMC Pregnancy Childbirth 2009, 9:29-34.
27. Shakur H., Elbourne D., Gülmezoglu M., Alfirevic Z., Ronsmans C., Allen E., et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of post-partum haemorrhage: an international randomized double blind placebo controlled trial. Trials 2010, 11:40.
28. Alfirevic Z., Elbourne D., Pavord S., Bolte A., Van Geijn H., Mercier F., et al. Use of recombinant activated factor vii in primary postpartum hemorrhage. The Northern European Registry 2000-2004. Obstet Gynecol 2007, 110:1270-1278.
29. Allam J., Cox M., Yentis S.M. Cell salvage in obstetrics. Int J Obstet Anesth 2008, 17:37-45.
30. Mercier F.J., Van de Velde M. Massive obstetric haemorrhage. Anesthesiol Clin 2008, 26:53-66.
31. Ducloy-Bouthors A.S., Ducloy J.C., Sicot J. Impact of a perinatal network medical practice improvement program on postpartum hemorrhage-related morbidity. Int J Gynecol Obstet 2009, 104:68-76.